Evidence-base medicine: is combination of clopidogrel and proton pump inhibitors safe?
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: SYU, Fei-Kai (Fooyin Univ. Hosp. Taiwan, China & Johns Hopkins Bloomberg Sch. of Public Health, Baltimore, United States of America)
- Co-author(s): Lai, Sow-Fei (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
Huang, Yu-Yao (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
Liu, Keh-Ren (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
Lin, Chien-Liang (Fooyin University Hospital, PINGTUNG, China Taiwan)
Background: Regarding the potential interaction of Proton Pump Inhibitors (PPIs) with PlavixÂ® (Clopidogrel), this potential interaction could lead to a reduction in the level of Clopidogrel's active metabolite and therefore, it is what we are eager to figure out its influences.
Using evidence-based medicine, 822 inpatients with single.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.